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Abstract
Background: Acute myocardial infarction (AMI) is a common high-risk disease with inpatient mortality of 5%
nationally. But little is known about this outcome among Asian Americans (Asians), a fast growing racial/ethnic
minority in the country. The objectives of the study are to obtain near-national estimates of differences in AMI
inpatient mortality between minorities (including Asians) and non-Hispanic Whites and identify comorbidities and
sociodemographic characteristics associated with these differences.
Method: This is a retrospective analysis of 2010–2011 state inpatient discharge data from 10 states with the largest
share of Asian population. We identified hospitalization with a primary diagnosis of AMI using the ICD-9 code and
used self-reported race/ethnicity to identify White, Black, Hispanic, and Asian. We performed descriptive analysis of
sociodemographic characteristics, medical comorbidities, type of AMI, and receipt of cardiac procedures. Next, we
examined overall inpatient AMI mortality rate based on patients’ race/ethnicity. We also examined the types of AMI
and a receipt of invasive cardiac procedures by race/ethnicity. Lastly, we used sequential multivariate logistic regression
models to study inpatient mortality for each minority group compared to Whites, adjusting for covariates.
Results: Over 70% of the national Asian population resides in the 10 states. There were 496,472 hospitalizations with a
primary diagnosis of AMI; 75% of all cases were Whites, 10% were Blacks, 12% were Hispanics, and 3% were Asians.
Asians had a higher prevalence of cardiac comorbidities, including hypertension, diabetes, and kidney failure compared
to Whites (p-value< 0.01). There were 158,623 STEMI (ST-elevation AMI), and the proportion of hospitalizations for STEMI
was the highest for Asians (35.2% for Asians, 32.7% for Whites, 25.3% for Blacks, and 32.1% for Hispanics). Asians had
the highest rates of inpatient AMI mortality: 7.2% for Asians, 6.3% for Whites, 5.4% for Blacks, and 5.9% for Hispanics
(ANOVA p-value < 0.01). In adjusted analyses, Asians (OR = 1.11 [95% CI: 1.04–1.19]) and Hispanics (OR = 1.14 [1.09–1.19])
had a higher likelihood of inpatient mortality compared to Whites.
Conclusions: Asians had a higher risk-adjusted likelihood of inpatient AMI mortality compared to Whites. Further
research is needed to identify the underlying reasons for this finding to improve AMI disparities for Asians.
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Background
Coronary artery disease is a common condition that
affects 15 million adults in the US and about 715,000
people have acute myocardial infarction (AMI) annually
[1]. AMI mortality has been significantly reduced with
advances in care, standardization of AMI management,
and modifications of AMI-related risk factors [2–4].
Despite these improvements, there exist significant racial
and ethnic disparities in the treatment and outcome of
AMI [5–21]. These studies have shown that minorities,
mostly non-Hispanic Blacks and Hispanics, are less likely
to have cardiac invasive procedures and have higher AMI
mortality compared to non-Hispanic Whites. However,
little is known about inpatient AMI mortality of Asians
residing in the US due to limited numbers of national data
that identify Asians (e.g. the National Health and Nutri-
tion Examination Survey only started to identify Asians
starting 2011).
Asian Americans (henceforth referred to as Asians), in-
cluding Pacific Islanders, make up 4.8% of the US popula-
tion and the population has been growing faster than the
national rate [22]. Overall, Asians in the population have a
relatively low prevalence of AMI-related comorbidities, in-
cluding obesity, diabetes, smoking, and hypertension
[23–26] and a relatively low national AMI mortality
rate (age-adjusted AMI mortality rate from death cer-
tificate for non-Hispanic White men was 196.7/
100,000 population and Asian men was 109.1/100,000
population in 1998) [27]. Despite studies that have
examined health disparities involving Asians for other
medical conditions such as stroke [28, 29], previous
research looking at racial/ethnic disparities in AMI
outcomes is limited. Many AMI studies have focused
on non-Asian minorities in the US or involved Asians
residing in Asian countries [29–32]. These studies
showed mixed results, ranging from no differences to
significant differences in outcomes.
To address the gaps in the literature on differences in
AMI outcomes among Asian Americans and to provide
updates in national AMI outcomes, we investigated the
following research questions using comprehensive data
from 10 states that together account for over 70% of the
national Asian American (Asian) population: [1] Are there
differences in observed AMI inpatient mortality
between each of the minority groups (Asians, Blacks,
or Hispanics) and Whites? [2] What is the risk-
adjusted inpatient AMI mortality of minorities com-
pared to Whites? [3] What are the sociodemographic
and clinical characteristics associated with inpatient
AMI mortality? By answering these questions, we
want to understand racial/ethnic differences in in-
patient AMI mortality as well as identify characteris-
tics that are associated with differences in AMI
inpatient mortality.
Methods
Study population
Our primary data was the 2010–2011 state inpatient
discharge data, containing all patient discharges at non-
federal short-term acute hospitals, from 10 US states -
California, Florida, Illinois, Massachusetts, Maryland,
New Jersey, New York, Pennsylvania, Texas, and
Virginia. These states were selected based on having
sizable Asian populations and the completeness of
race/ethnicity reporting in the discharge data. Data
for California, Texas, Illinois, Pennsylvania, Massachu-
setts, and Virginia were obtained from the respective
state agencies [33], and data for remaining states were
obtained from AHRQ HCUP Central Distributor [34].
The data was built and designed after the Feng et al. paper
[35]. The selected 10 states contained 70% of the national
Asian population (Appendix 1). We identified all dis-
charges for adult patients aged 18 and older with the prin-
cipal diagnosis of AMI (ICD-9: 410) [36]. We excluded
64,561 patients who were transferred to another short-
term hospital, admitted with obstetric-related conditions,
and missing key variables (discharge disposition, gender,
age, discharge quarter/year, principal diagnosis, or admis-
sion information) [37].
Race/ethnicity
We used self-reported race/ethnicity and categorized
patients into the following race/ethnicity groups:
Hispanics, (non-Hispanic) Whites, (non-Hispanic) Blacks,
(non-Hispanic) Asians, Others or unknown (i.e., missing).
For the subjects with missing race/ethnicity information
(2.6% of the study population), race/ethnicity was re-
assigned using the “hot-deck” statistical imputation
method [38]. This method randomly assigns race/eth-
nicity for patients with missing race/ethnicity in the
same proportion as the race/ethnicity distribution for
those with known race/ethnicity. As previous studies
have indicated that Others include a sizable propor-
tion of Whites, we grouped Others with Whites in all
the analyses [39].
Covariates
Based on previous studies, we identified key demo-
graphics, comorbidities, types of AMI, and use of in-
vasive cardiac procedures that were associated with
AMI mortality. Socio-demographic variables included
sex, age, and state of residence [17, 40–44]. We cate-
gorized age into seven groups: 18–34, 35–44, 45–54,
55–64, 65–74, 75–84, and 85+. We used Elixhauser
categories to identify comorbidities and determined
whether the patient had the comorbid condition or
not (comorbid conditions include congestive heart
failure, cardiac arrhythmias, valvular disease, pulmon-
ary circulation disorders, peripheral vascular disease,
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hypertension, paralysis, other neurological disorders,
chronic pulmonary disease, diabetes (uncomplicated),
diabetes with chronic complications, hypothyroidism,
renal failure, liver disease, peptic ulcer disease without
bleeding, acquired immune deficiency syndrome,
lymphoma, metastatic cancer, solid tumor without
metastasis, rheumatoid arthritis/collagen vascular
diseases, coagulopathy, obesity, weight loss, fluid and
electrolyte disorders, blood loss anemia, deficiency
anemias, alcohol abuse, drug abuse, psychoses,
depression) [45]. Using secondary diagnosis codes
reported in the index discharge records, the Elixhau-
ser method identifies 30 risk groups associated with
inpatient mortality; these are defined as 30 separate
indicator (0/1) fields. For types of AMI, we diffe-
rentiated AMI cases into non-ST-segment elevation
(NSTEMI) (ICD-9 = 410.7) and ST-segment elevation MI
(STEMI) (all ICD-9 = 410 excluding 410.7). We used diag-
nosis and procedure codes from the International Classifi-
cation of Diseases, Ninth Revision, Clinical modification
and corresponding Current Procedural Terminology to
code for the invasive cardiac procedures of coronary
artery bypass surgery (CABG) and percutaneous coronary
intervention (PCI) [36].
Primary outcome: Inpatient acute MI mortality
The main outcome was inpatient mortality from a
hospitalization for AMI (ICD-9: 410). This is one of the
Inpatient Quality Indicators measured by the Agency for
Healthcare Research and Quality (AHRQ) [37].
Statistical analysis
Statistical analysis was conducted using SAS software,
version 9.3 (SAS Institute Inc., Cary, NC). We
performed descriptive analysis of socio-demographic
characteristics, medical comorbidities, and types of AMI
based on patients’ race/ethnicity. We performed chi-
square and t-tests to compare differences between each
of the minority groups and Whites. Next, we examined
use of PCI and CABG for overall AMI, and then among
those with STEMI and NSTEMI.
We used multivariable logistic regression models to
study differences in inpatient mortality among racial/
ethnic minorities (Asians, Hispanics, and Blacks) com-
pared to Whites. To better identify the source of differ-
ences in inpatient mortality, we estimated odds ratios in
a sequence of models, adjusting for a wider array of co-
variates in the following order: age, gender, geographical
location (state), co-morbidities (Elixhauser categories),
type of AMI, and invasive cardiac procedures (CABG
and PCI). We did not correct for multiple testing. Sensi-
tivity analyses were performed to examine disparities in
AMI mortality among those who were transferred from
another short-term hospital, since this subgroup of
patients may be systematically different in severity.
The Boston University Institutional Review Board
approved this study.
Results
We identified 561,041 AMI cases. Of these, we
excluded 62,267 (11.1%) AMI admissions that were
transferred to another hospital as we do not have in-
formation regarding their health outcomes (percent-
ages of each racial/ethnic groups excluded: Asians =
14.5%, White = 10.9%, Black = 11.3%, and Hispanics =
11.3%). In addition, we excluded 2302 (0.4%) AMI
cases with obstetric-related conditions or missing key
variables. The study sample included 496,472 AMI
cases.
Socio-demographic characteristics
Table 1 shows the characteristics of the total sample
as well as subgroups of the different racial/ethnic
groups. The majority of the study population were
White (75%), followed by 12% Hispanics, 10% Black,
and 3% Asian. There was a significant difference in
mean age and percentages of women in different ra-
cial/ethnic groups (ANOVA; p-value < 0.01 for both).
Mean average age was the oldest for White (mean
age = 69.4 years old) and the youngest for Black
(mean age = 63.8 years old). Significantly higher per-
centage of Black patients (48.0%) and lower percent-
age of Asian patients (35.2%) were women compared
to Whites (39.4%) (p-values< 0.05). There were wide
variations in racial/ethnic composition in each of the
10 states.
Clinical characteristics
We examined the prevalence of each of the comor-
bidities in the Elixhauser comorbidity index (Table 2).
Compared to Whites, Asians had a mixed profile of
comorbid conditions, with lower prevalence of some
conditions (obesity, cardiac arrhythmia, and periph-
eral vascular disease), but higher prevalence of a
wider range of conditions (congestive heart failure,
diabetes, hypertension, renal failure, and coagulopa-
thy) (all p-values were less than 0.01). There were
significant racial/ethnic differences in the average
length of stay and number of Elixhauser comorbidity
diagnoses (ANOVA; both p-value < 0.01). Among
different groups, each of the minority groups had
longer average length of stay and Blacks had the
highest average number of diagnoses (11.6 diagnoses)
compared to Whites (Table 3).
Next, we differentiated type of AMI; there were
337,849 (68.0%) hospitalizations for NSTEMI and
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Table 2 Prevalence of co-morbidities (Elixhauser comorbidities) by race/ethnicity
Variable Asian
(n = 14,977)
White
(n = 372,556)
Black
(n = 51,403)
Hispanic
(n = 57,536)
% of AMI hospitalizations with the comorbidities
Congestive heart failure 34.5 31.9 35.5 32.0*
Cardiac arrhythmias 36.5 39.5 31.8 31.3
Peripheral vascular disease 9.4 11.3 11.2* 10.6
Hypertension 75.7 70.5 82.4 75.9
Chronic pulmonary disease 13.6 20.5 18.5 14.9
Diabetes, uncomplicated 33.6 26.4 34.1 38.8
Diabetes with chronic complications 11.7 5.7 9.0 10.3
Renal failure 26.6 18.3 28.1 22.0
Coagulopathy 7.4 5.0 4.9* 5.2*
Deficiency anemias 23.1 15.4 21.8 19.4
*P-value ≥ 0.05 when each of the racial/ethnic group (Asian, White, or Black) was compared to White (unmarked signify p-value < 0.05)
Table 1 Socio-demographic characteristics of AMI hospitalizations by race/ethnicitya*
Variable All (n = 496,472) Asian (n = 14,977) White (n = 372,556) Black (n = 51,403) Hispanic (n = 57,536)
Age
Mean age, years old (SD) 68.3 (14.7) 67.2 (14.5) 69.4 (14.5) 63.8 (14.6)* 65.3 (14.4)*
Age groups (%)
18–34 0.8 1.0 0.6 1.7 1.4
35–44 4.3 5.1 3.7 6.9 5.9
45–54 14.3 14.6 13.2 19.8 17.0
55–64 22.0 22.9 21.1 25.1 24.5
65–74 21.4 22.2 21.2 21.1 22.2
75–84 21.3 20.9 22.4 16.4 19.0
85+ 15.9 13.3 17.9 9.0 10.0
Gender
Women (%) 40.0 35.2* 39.4 48.0* 37.7
State of residence** (%)
California n = 92,285 9.6 63.6 7.2 19.6
Florida n = 78,753 0.7 75.8 9.4 14.1
Illinois n = 39,950 2.0 78.1 14.1 5.8
Massachusetts n = 23,176 1.7 90.2 4.0 4.0
Maryland n = 15,523 1.9 72.5 24.0 1.6
New Jersey n = 29,662 3.0 76.8 11.3 8.8
New York n = 59,521 2.7 78.9 10.7 7.8
Pennsylvania n = 57,160 0.5 89.8 7.8 2.0
Texas n = 74,553 1.3 66.3 10.9 21.6
Virginia n = 25,889 1.6 67.6 18.3 1.5
aValues are means (standard deviation) or percentages of patients
*P-value< 0.05 when each of the racial/ethnic group (Asian, White, or Black) was compared to White
**Racial/ethnic distribution in each state
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158,623 (32.0%) hospitalizations for STEMI (Table 3).
Significantly higher proportion of Asians (35.2%) had
STEMI and lower proportions of Blacks (25.3%) or His-
panics (32.1%) had STEMI compared to Whites (32.7%)
(p-values < 0.05). We also examined the prevalence of
cardiac procedure use, specifically percutaneous cor-
onary intervention (PCI) and coronary artery bypass
graft (CABG). Among AMI hospitalization by Asians,
48.0% received PCI and 10.6% received CABG; this is
similar for PCI and higher for CABG compared to
Whites. Regardless of type of procedure or AMI,
Blacks had the lowest rate of cardiac procedures dur-
ing the hospitalization. In regards to mortality after
cardiac procedures (PCI or CABG), Asians had higher
mortality compared to non-Asians (p < 0.01), specific-
ally after PCI (Appendix 2).
Observed inpatient AMI mortality
There were significant differences in observed
inpatient AMI mortality among different racial and
ethnic groups. Asians had the highest observed
inpatient AMI mortality (inpatient mortality Asian =
7.2%; White = 6.3%; Black = 5.4%, and Hispanic = 5.9%).
This finding persisted for both STEMI (inpatient
mortality Asian = 10.4%; White = 9.4%; Black = 9.8%,
and Hispanic = 8.8%) and NSTEMI (inpatient
mortality Asian = 5.4%; White = 4.8%; Black = 3.9%,
and Hispanic = 4.6%).
Table 4 Odds ratio [95% confidence interval] of inpatient AMI mortality associated with race/ethnicity (reference: non-Hispanic White)
Asian Black Hispanic
(n = 14,977) (n = 51,403) (n = 57,536)
Model 1: Unadjusted 1.16 [1.09–1.23] 0.85 [0.81–0.88] 0.94 [0.91–0.97]
Model 2: Model 1+ Age group 1.27 [1.19–1.35] 1.06 [1.02–1.11] 1.11 [1.07–1.15]
Model 3: Model 2+ Gender 1.27 [1.19–1.35] 1.06 [1.02–1.11] 1.11 [1.07–1.15]
Model 4: Model 3+ Geography (state) 1.21 [1.14–1.30] 1.05 [1.00–1.09] 1.09 [1.05–1.13]
Model 5: Model 4+ Patient comorbidities (Elixhauser grouping) 1.13 [1.06–1.21] 1.04 [1.00–1.09] 1.15 [1.10–1.19]
Model 6: Model 5+ Type of AMI 1.12 [1.04–1.20] 1.12 [1.07–1.17] 1.17 [1.12–1.22]
Model 7: Model 6+ Receipt of PTCA or CABG 1.11 [1.04–1.19] 1.02 [0.98–1.06] 1.14 [1.09–1.19]
Table 3 Clinical characteristics of AMI hospitalizations by race/ethnicitya
Variable Asian White Black Hispanic
Number of diagnoses (SD) 11.3 (6.2) 11.3 (5.2) 11.6 (5.2)* 10.8 (5.2)*
Length of stay, days (SD) 6.2 (7.4)* 5.3 (17.4) 5.6 (7.0)* 5.9 (19.5)*
Types of AMI
STEMI 35.2* 32.7 25.3* 32.1*
NSTEMI 64.8* 67.3 74.7* 67.9*
Receipt of invasive cardiac procedures
PCI 48.0 48.2 41.0* 47.6*
CABG 10.6* 9.3 6.5* 10.2*
Receipt of invasive cardiac procedures by AMI type
STEMI (n = 158,623)
PCI 69.5 72.1 68.1* 72.2
CABG 8.0* 7.3 5.4* 8.1*
NSTEMI (n = 337,849)
PCI 36.3 36.5 31.9* 35.9*
CABG 12.0* 10.2 6.9* 11.3*
aValues are means (standard deviation) or percentages of patients
*P-value< 0.05 when each of the racial/ethnic group (Asian, White, or Black) was compared to White
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Models of inpatient AMI mortality adjusting for covariates
We examined the racial/ethnic differences in AMI
mortality using a sequence of multivariable logistic
models, cumulatively including covariates from the differ-
ent domains (Table 4). Model 1 (which only included
race/ethnicity variable) reported higher unadjusted AMI
mortality among Asians (odds ratio (OR) = 1.16 [95% CI:
1.09–1.23]) compared to Whites; in contrast, Blacks (OR
= 0.85 [0.81–0.88]) and Hispanics (OR = 0.94 [0.91–0.97])
had lower mortality. After adjusting for age differences
(model 2), all minority groups (Asian OR = 1.27 [95% CI:
1.19–1.35], Black OR = 1.06 [95% CI: 1.02–1.11], and His-
panic OR = 1.11 [95% CI: 1.07–1.15]) had higher mortal-
ity compared to Whites. This trend persisted even
after adjusting for gender, state of residence, and
comorbidities; however, the Asian versus White gap
decreased after accounting for differences in comorbid-
ities (Model 5). When type of AMI was included in the
analysis (Model 6), likelihood of AMI mortality
increased and became significant for Blacks compared
to Whites. In the final model (Model 7), there was a
shift in AMI mortality among Blacks (from OR = 1.12
[1.07–1.17] to OR = 1.02 [95% CI: 0.98–1.06]) when in-
vasive cardiac procedures were included in the model.
Including the cardiac procedure covariate did not
change the significance of AMI mortality of either
Asians (OR = 1.11 [1.04–1.19]) or Hispanics (OR = 1.14
[1.09–1.19]) when compared to Whites. Sensitivity ana-
lysis looking at the subgroup of AMI hospitalizations of
patients transferred from another short-term hospital
(n = 81,888) showed no significant difference in inpatient
AMI mortality between minorities and White (Asian
OR = 0.86 [0.68–1.08]; Black OR = 0.94 [0.82–1.08];
and Hispanic OR = 1.02 [0.89–1.16]) after adjusting
for covariates.
Discussion
Using comprehensive AMI discharge data from 10 states
that contains 70% of the U.S. population of Asians, we
found that Asians had the highest observed inpatient
AMI mortality. There were differences in sociodemo-
graphic and clinical characteristics among different ra-
cial/ethnic groups. In risk-adjusted inpatient mortality,
the extent of the mortality differences was reduced after
adjusting for comorbidities, an indication of higher
prevalence of comorbidities among Asians admitted with
AMI. In the final model adjusting for sociodemographic
characteristics, comorbidities, type of AMI, and invasive
cardiac procedure use, Asians and Hispanics remained
to have increased likelihoods of inpatient mortality com-
pared to Whites.
One plausible explanation for the higher AMI
inpatient mortality among Asians is higher disease bur-
den and severity, specifically among those with elevated
risk of AMI. As noted, there was a sizable reduction in
the AMI mortality among Asians after adjusting for
observed comorbidities, which indicates higher overall
comorbidity burden. This pattern of higher comorbidity
risk among Asian AMI hospitalizations contrasts with
epidemiologic evidence of lower disease burden among
the general population of Asians [23–26]. The popula-
tion level death rate from AMI is lower among Asians,
compared to Whites [27]; this is not inconsistent with
our finding of higher mortality among hospitalizations
for AMI, since our study does not take into account the
risk of being hospitalized (for AMI). The higher cardio-
vascular risk among some Asians may partly be ex-
plained by their recent adoption of western diet and
habits in the U.S. as well as worldwide [46, 47]. The shift
in cardiovascular risk factors are associated with accul-
turation, particularly the number of years residing in the
US [48–50]. Given no significant differences in likeli-
hoods of AMI mortality among those who were trans-
ferred from another short-term hospital, disparities are
not due to racial/ethnic differences in the proportion of
patients who were transferred across hospitals. Instead,
disparities were concentrated largely among cases where
patients were treated in the hospitals where they were
initially admitted.
Besides comorbidities, we observed higher AMI
inpatient mortality among Asians who had cardiac pro-
cedures. We do not have information regarding deci-
sions behind why patients received cardiac procedures
but the high cardiac procedure rate among Asians might
be due to more advanced or severe cases that require in-
vasive interventions. The higher mortality among those
receiving cardiac procedures needs further examination,
as identifying contributing factors can improve future
outcomes. If the high mortality is due to a high comor-
bidity burden, future studies should focus on re-
stratifying risk for all AMI patients. However, if the high
mortality is coming from procedure-related complica-
tions common among Asians, such as high bleeding risk
after anti-platelet therapy [51–53], then different medical
therapies, such as lower doses of antithrombotic medica-
tions, should be used. The absence of data about compli-
cations is a limitation of our study, thus we could not
examine this further. Also, Asians with AMI may seek
medical care when cardiac symptoms are severe and
have been present for longer durations. Delays in re-
ceiving care have been associated with poor outcomes
[54–56]. In a study that examined AMI patients ex-
periencing symptoms for less than 24 h, there was no
difference in mortality between Asians and Whites
[32]. Our study did not differentiate patients based on
their duration of symptoms, and the high mortality could
have originated from higher inpatient mortality among
Asians with longer duration of symptoms.
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Another explanation is that certain Asian subgroups
are contributing more to the high inpatient AMI mortal-
ity. Asians encompass diverse population and studies
have identified heterogeneity in cardiovascular disease
risk factors among Asians by country of origin. For ex-
ample, previous studies have identified that South Asians
have more cardiovascular risk factors and worse out-
comes compared to Whites [57–59]. In addition, another
study found that certain Asian and Hispanic ethnic
groups have significantly lower insurance rates [60] and
it is possible that these small groups of Asians with dis-
advantageous socioeconomic factors may experience a
significantly greater impact on AMI mortality due to
limited healthcare access and decreased preventive care
visits. Lastly, the presence of language barriers among
Asians with limited English proficiency could contrib-
ute to poor health outcomes [61, 62], and possibly
higher AMI mortality.
There are several limitations of this retrospective
observational study. Given our observational data, a
causal relationship cannot be established between
being Asian and increased inpatient AMI mortality.
Due to the nature of secondary, administrative data,
information on clinical patient status is limited. For
example, clinical information regarding duration or
severity of symptoms, admission vitals, EKG findings,
and procedure complications could have provided
further insight. The data also did not include medica-
tions, which would have been helpful in understand-
ing race/ethnicity-specific medical management of
AMI, or how clinical decisions were made in obtain-
ing invasive cardiac procedures. Previous research has
shown mixed results as to whether racial differences
existed in decision-making involving invasive cardiac
procedures [14, 63]. We are missing data in some
states on other covariates such as health insurance
status, educational achievement, and household in-
come, which could affect patients’ access and decision
to seek medical care for AMI. Our data also does not
contain acculturation information, which could indir-
ectly provide immigrants’ newly adopted cardiovascu-
lar risks. The findings may not be generalizable to
states with small Asian populations, since we only in-
cluded 10 states with a sizeable Asian population.
Lastly, there has been a significant increase in multi-
racial populations, especially Asians tied to other
races or ethnicities [22]. For our study, we used self-
reported race/ethnicity, which did not identify multi-
racial patients.
Conclusion
These data are among the first to show that Asian
patients hospitalized with acute myocardial infarction
had higher observed AMI mortality than Black, His-
panic, or White patients. The findings may have been
driven by higher disease severity, heterogeneous risk-
associated with Asian subgroups, and delayed medical
care. We observed higher inpatient AMI mortality
among Asians compared to Whites even after adjust-
ing for sociodemographic and clinical characteristics.
With the increasing number of Asians in the US, dis-
parities in AMI mortality will become more signifi-
cant. Further research should focus on patient-level
details to better understand the heterogeneity of the
Asian population and clinical factors associated with
such disparities.
Appendix 1
Table 5 2010–2011 Census population and crude state-level counts of AMI by race/ethnicity (Age 18+)
Crude state-level counts of AMI State share (%) of national census population of adults, 2010
State Asian White Black Hispanics All Asian White Black Hispanics All
California 8815 58,703 6673 18,094 92,285 33.1% 7.9% 6.1% 27.8% 11.9%
New York 1610 46,953 6338 4620 59,521 9.7% 5.8% 8.2% 7.3% 6.4%
Texas 949 49,415 8105 16,084 74,553 6.6% 5.8% 7.6% 18.4% 7.8%
New Jersey 899 22,792 3359 2612 29,662 4.9% 2.6% 3.1% 3.3% 2.9%
Illinois 784 31,217 5648 2301 39,950 4.0% 4.1% 4.8% 3.9% 4.1%
Florida 522 59,677 7423 11,131 78,753 3.1% 5.8% 7.6% 9.4% 6.3%
Virginia 425 20,340 4744 380 25,889 3.0% 2.6% 4.1% 1.3% 2.6%
Massachusetts 398 20,912 936 930 23,176 2.4% 2.6% 1.1% 1.2% 2.2%
Maryland 295 11,248 3731 249 15,523 2.2% 1.6% 4.5% 1.0% 1.9%
Pennsylvania 280 51,299 4446 1135 57,160 2.4% 5.2% 3.5% 1.4% 4.2%
Total 14,977 372,556 51,403 57,536 496,472 76.0% 50.4% 52.6% 84.6% 56.8%
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